SCHEMBL4317889

SCHEMBL4317889

Nc1cc(N2CCOCC2)ccc1/C=C/c1n[nH]c2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.55
FLT1 P17948 3/20 0.55
ITK Q08881 1/20 0.51
LRRK2 Q5S007 3/20 0.48
PDGFRB P09619 1/20 0.46
KDR P35968 1/20 0.46
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
THRB P10828 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.40
LGMN Q99538 1/20 0.40
NPC1 O15118 1/20 0.40
ALOX15 P16050 1/20 0.40
RAB9A P51151 1/20 0.40
CBFB Q13951 1/20 0.40
GAA P10253 1/20 0.40
CDC7 O00311 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4317893 1.00 FGFR1 (0.55) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4326947 0.91 FGFR1 (0.53) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4326946 0.91 FGFR1 (0.53) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4327057 0.83 FGFR1 (0.42) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4327051 0.83 FGFR1 (0.42) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL27691469 0.83 FGFR1 (0.51) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4312073 0.83 FGFR1 (0.41) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4312068 0.83 FGFR1 (0.41) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL27691456 0.83 FGFR1 (0.41) FGFR1FLT1ITKLRRK2PDGFRB
SCHEMBL4317941 0.81 FGFR1 (0.42) FGFR1FLT1LRRK2AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 FGFR1 18/4885FLT1 81/4885ITK 1951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.